Trial Profile
A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Aug 2023
Price :
$35
*
At a glance
- Drugs Mepolizumab (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 05 Nov 2010 New trial record.